Yale investigators report findings regarding in-vitro Heparin

A group of investigators at Yale recently reported that in-vitro Heparin induces potentially detrimental proinflammatory and antiangiogenic profile in the trophoblast.The authors concluded that their findings may explain the inability of current therapies to consistently prevent adverse outcomes. This study was recently published in Obstetrics and Gynecology – November 2011. Details about this study can be found here.